About the Authors
- Enrico Ferrero
-
* E-mail: enrico.ferrero@novartis.com
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Sophie Brachat
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Jeremy L. Jenkins
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America
- Philippe Marc
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Peter Skewes-Cox
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Emeryville, California, United States of America
- Robert C. Altshuler
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America
- Caroline Gubser Keller
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Audrey Kauffmann
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland
- Erik K. Sassaman
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America
- Jason M. Laramie
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America
- Birgit Schoeberl
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America
- Mark L. Borowsky
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, United States of America
- Nikolaus Stiefl
-
Affiliation Computational Sciences Council, Novartis Institutes for BioMedical Research, Basel, Switzerland
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: All authors are Novartis employees and Novartis shareholders.